| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $236.3M | +15.4% |
| Cost of Revenue | $63.7M | +13.5% |
| Gross Profit | $172.7M | +16.2% |
| R&D Expense | $9.1M | -17.5% |
| SG&A Expense | $119.8M | +16.6% |
| Operating Income | -$39.2M | -12.1% |
| Interest Expense | $27K | -22.9% |
| Pre-tax Income | -$39.2M | +6.5% |
| Income Tax | $460K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.6M | -55.4% |
| Short-term Investments | $41.3M | +65.1% |
| Accounts Receivable | $53.8M | +27.1% |
| Inventory | $133.8M | +14.3% |
| Current Assets | $256.4M | +8.1% |
| Total Assets | $508.6M | +7.5% |
| Current Liabilities | $46.2M | +36.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | +82.1% |
| Capital Expenditures | $11.1M | -22.1% |
| Investing Cash Flow | -$43.6M | -231.5% |
| Financing Cash Flow | $24.0M | -54.9% |
| Free Cash Flow | -$16.0M | +61.4% |
| +111.2% |
| Net Income | -$39.6M | -4.8% |
| EPS (Basic) | -$1.69 | -3.0% |
| EPS (Diluted) | -$1.69 | -3.0% |
| Long-term Debt |
| $106.0M |
| +36.8% |
| Total Liabilities | $162.0M | +36.6% |
| Stockholders' Equity | $346.6M | -2.2% |